Lawyer profile
Stephen Nicolai
Hogan Lovells
- Firm
- Hogan Lovells
- Practice
- capital markets
- Office
- Philadelphia
- Active in the record
- 2021 to 2025
Deal experience
Deal types
Sectors
Jurisdictions
Deals
7 announced deals in the record Hogan Lovells advises EyePoint on its US$150 million follow-on public offering of equity securities 26 Oct 2025
Hogan Lovells advises HLS Therapeutics on the sale of its XENPOZYME® Royalty Interest 15 Jul 2024
Hogan Lovells advises Perspective Therapeutics in its US$80 million underwritten offering of equity securities 4 Jun 2024
Hogan Lovells represents Optinose in its US$55 million registered direct offering 30 May 2024
Hogan Lovells advises Omega Therapeutics on research collaboration transaction with Novo Nordisk and Flagship Pioneering 12 Jan 2024
Hogan Lovells advises EyePoint Pharmaceuticals on its $230 million follow-on public offering of common stock 9 Dec 2023
Hogan Lovells assists EyePoint Pharmaceuticals on transformative follow-on public offering of common stock 9 Feb 2021
Deal alerts PRO
Get an email when Stephen Nicolai is named on a newly announced deal.
Alerts come as one daily email at most.
Analytics
Based on announced deals in DealDatabaseLoading analytics…
Complete deal history
Is this you?
Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.
Claim this profile